Beta Bionics, Inc. 10-K filing
Filed 2026-02-24 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001193125-26-067065
- Form type
- 10-K
- CIK
- 0001674632
- Primary document
- https://www.sec.gov/Archives/edgar/data/1674632/000119312526067065/bbnx-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Beta Bionics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $100.3M | - | - |
| Cost Of Revenue | $44.7M | - | - |
| Gross Profit | $55.5M | - | - |
| Operating Income | $-71.7M | - | - |
| Net Income | $-73.2M | - | - |
| Eps Basic | -1.81 | - | - |
| Eps Diluted | -1.81 | - | - |
| Cash And Equivalents | $31.6M | - | - |
| Total Assets | $328.7M | - | - |
| Total Liabilities | $41.1M | - | - |
| Shareholders Equity | $287.6M | - | - |
| Operating Cash Flow | $-50.9M | - | - |
| Capital Expenditures | $5.3M | - | - |